Investor Presentaiton
Updates of Investment Activities
ā Tigermed
Realized Investment Gain
and Fair Value Gain(1)
(RMB mm)
50.1
413.3
1 H2022
34.9
529.8
Portfolio included 158 companies in the healthcare
industry and 59 investment funds as of June 30, 2023
RMB 10,633.3 mm balance as of June 30, 2023
Invested RMB 239.3 mm in unlisted equities; and RMB
22.9 mm in investment funds in 1H2023
Received RMB 383.4 mm cash from investment exits in
1H2023
In 1H2023, we realized a gain of RMB 152.3 million from
exiting our portfolio companies and funds, as measured by
the exit amount against our initial investment cost
1H2023
Realized investment gain
Fair value gain
(1) Realized Investment gain indicates gain on disposal of or dividends from financial assets at fair value through profit or loss ("FVTPL") and gain on disposal of associates or subsidiaries for investment purposes;
fair value gain indicates change in fair value of financial assets at FVTPL
24
24View entire presentation